Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:467-475
Published online before print February 3, 2005, doi: 10.1161/01.RES.0000158286.51045.16
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
96/4/467    most recent
01.RES.0000158286.51045.16v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikeda, S.
Right arrow Articles by Alexander, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikeda, S.
Right arrow Articles by Alexander, R. W.
Related Collections
Right arrow Other Vascular biology
Right arrow Angiogenesis
(Circulation Research. 2005;96:467.)
© 2005 American Heart Association, Inc.


Molecular Medicine

Novel Role of ARF6 in Vascular Endothelial Growth Factor–Induced Signaling and Angiogenesis

Satoshi Ikeda*, Masuko Ushio-Fukai*, Lian Zuo, Taiki Tojo, Sergey Dikalov, Nikolay A. Patrushev, R. Wayne Alexander

From the Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Ga.

Correspondence to Masuko Ushio-Fukai, PhD, Division of Cardiology, Emory University School of Medicine, 1639 Pierce Dr, Rm 319, Atlanta, GA 30322. E-mail mfukai{at}emory.edu

Vascular endothelial growth factor (VEGF) stimulates endothelial cell (EC) migration and proliferation primarily through the VEGF receptor-2 (VEGFR2). We have shown that VEGF stimulates a Rac1-dependent NAD(P)H oxidase to produce reactive oxygen species (ROS) that are involved in VEGFR2 autophosphorylation and angiogenic-related responses in ECs. The small GTPase ARF6 is involved in membrane trafficking and cell motility; however, its roles in VEGF signaling and physiological responses in ECs are unknown. In this study, we show that overexpression of dominant-negative ARF6 [ARF6(T27N)] almost completely inhibits VEGF-induced Rac1 activation, ROS production, and VEGFR2 autophosphorylation in ECs. Fractionation of caveolae/lipid raft membranes demonstrates that ARF6, Rac1, and VEGFR2 are localized in caveolin-enriched fractions basally. VEGF stimulation results in the release of VEGFR2 from caveolae/lipid rafts and caveolin-1 without affecting localization of ARF6, Rac1, or caveolin-1 in these fractions. The egress of VEGFR2 from caveolae/lipid rafts is contemporaneous with the tyrosine phosphorylation of caveolin-1 (Tyr14) and VEGFR2 and with their association with each other. ARF6(T27N) significantly inhibits both VEGF-induced responses. Immunofluorescence studies show that activated VEGFR2 and phosphocaveolin colocalize at focal complexes/adhesions after VEGF stimulation. Both overexpression of ARF6(T27N) and mutant caveolin-1(Y14F), which cannot be phosphorylated, block VEGF-stimulated EC migration and proliferation. Moreover, ARF6 expression is markedly upregulated in association with an increase in capillary density in a mouse hindlimb ischemia model of angiogenesis. Thus, ARF6 is involved in the temporal-spatial organization of caveolae/lipid rafts– and ROS-dependent VEGF signaling in ECs as well as in angiogenesis in vivo.


Key Words: ARF6 • caveolin • vascular endothelial growth factor • endothelial cell • angiogenesis




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Rask-Madsen and G. L. King
Differential Regulation of VEGF Signaling by PKC-{alpha} and PKC-{epsilon} in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 919 - 924.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Serini, L. Napione, M. Arese, and F. Bussolino
Besides adhesion: new perspectives of integrin functions in angiogenesis
Cardiovasc Res, May 1, 2008; 78(2): 213 - 222.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Wu, V. Rizzo, Y. Liu, I. M. Sainz, N. G. Schmuckler, and R. W. Colman
Kininostatin Associates With Membrane Rafts and Inhibits {alpha}v{beta}3 Integrin Activation in Human Umbilical Vein Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): 1968 - 1975.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. H. Chidlow Jr., D. Shukla, M. B. Grisham, and C. G. Kevil
Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues
Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G5 - G18.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Bouzin, A. Brouet, J. De Vriese, J. DeWever, and O. Feron
Effects of Vascular Endothelial Growth Factor on the Lymphocyte-Endothelium Interactions: Identification of Caveolin-1 and Nitric Oxide as Control Points of Endothelial Cell Anergy
J. Immunol., February 1, 2007; 178(3): 1505 - 1511.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. V. Backer, V. Patel, B. T. Jehning, K. P. Claffey, V. A. Karginov, and J. M. Backer
Inhibition of Anthrax Protective Antigen Outside and Inside the Cell
Antimicrob. Agents Chemother., January 1, 2007; 51(1): 245 - 251.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Q. Zhou, L.-Z. Liu, B. Fu, X. Hu, X. Shi, J. Fang, and B.-H. Jiang
Reactive oxygen species regulate insulin-induced VEGF and HIF-1{alpha} expression through the activation of p70S6K1 in human prostate cancer cells
Carcinogenesis, January 1, 2007; 28(1): 28 - 37.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Ushio-Fukai and R. W. Alexander
Caveolin-Dependent Angiotensin II Type 1 Receptor Signaling in Vascular Smooth Muscle
Hypertension, November 1, 2006; 48(5): 797 - 803.
[Full Text] [PDF]


Home page
Sci SignalHome page
M. Ushio-Fukai
Localizing NADPH Oxidase-Derived ROS
Sci. Signal., August 22, 2006; 2006(349): re8 - re8.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
M. G. Lampugnani, F. Orsenigo, M. C. Gagliani, C. Tacchetti, and E. Dejana
Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments
J. Cell Biol., August 14, 2006; 174(4): 593 - 604.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Ushio-Fukai
Redox signaling in angiogenesis: Role of NADPH oxidase
Cardiovasc Res, July 15, 2006; 71(2): 226 - 235.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Moldovan, K. Mythreye, P. J. Goldschmidt-Clermont, and L. L. Satterwhite
Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1
Cardiovasc Res, July 15, 2006; 71(2): 236 - 246.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-C. Zeeh, M. Zeghouf, C. Grauffel, B. Guibert, E. Martin, A. Dejaegere, and J. Cherfils
Dual Specificity of the Interfacial Inhibitor Brefeldin A for Arf Proteins and Sec7 Domains
J. Biol. Chem., April 28, 2006; 281(17): 11805 - 11814.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Mukherjee, M. Tessema, and A. Wandinger-Ness
Vesicular Trafficking of Tyrosine Kinase Receptors and Associated Proteins in the Regulation of Signaling and Vascular Function
Circ. Res., March 31, 2006; 98(6): 743 - 756.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Ushio-Fukai, L. Zuo, S. Ikeda, T. Tojo, N. A. Patrushev, and R. W. Alexander
cAbl Tyrosine Kinase Mediates Reactive Oxygen Species- and Caveolin-Dependent AT1 Receptor Signaling in Vascular Smooth Muscle: Role in Vascular Hypertrophy
Circ. Res., October 14, 2005; 97(8): 829 - 836.
[Abstract] [Full Text] [PDF]